AI assistant
IMEXHS LIMITED — Capital/Financing Update 2021
Jan 4, 2021
65120_rns_2021-01-04_a991e27d-c2fe-4752-8a83-0b3baadb568c.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
==> picture [116 x 30] intentionally omitted <==
5 January 2021
ASX ANNOUNCEMENT
Strong finish to 2020 for new Aquila in the Cloud product offering
IMEXHS Limited (ASX: IME) (“IMEXHS” or “the Company”) announces that Aquila in the Cloud , its standardised radiology solution launched in May 2020, has signed a total of 41 deals as at 31 December which are expected to contribute over A$945,000 in Annual Recurring Revenue (ARR).
Aquila in the Cloud is a low-cost, rapidly deployed product offering that provides small to midsize customers with access to IMEXHS’s innovative medical imaging technology. It has continued to generate widespread demand with customers now located across 11 markets including the USA, where the first customer signed in Miami on 1 December, has now gone live with a 30-day trial. The highly scalable business model is supported by an extensive and growing network of distributor partners and sales opportunities continue to expand.
IMEXHS Co-founder and CEO, Dr German Arango said: “The strong demand we are experiencing in multiple markets for Aquila in the Cloud reflects the gap which exists for a low-cost radiology solution that meets the needs of small to mid-size operators. Our affordable product offering provides us with a unique opportunity to democratise access to medical imaging which is currently not available to around two-thirds of the world’s population. At IMEXHS, we firmly believe that Aquila in the Cloud represents an important step forward to improving the health outcomes of communities across the globe.”
Authorised for release by the Board of IMEXHS Limited.
-ENDS-
For more information, please contact:
Media and Investor Relations
Françoise Dixon, Citadel-MAGNUS E: [email protected]
T: +61 412 292 977
Business Inquiries
Reena Minhas – CFO & Company Secretary IMEXHS E: [email protected]
T: +61 (0)2-9030-0040
IMEXHS Limited ABN 60 096 687 839 Imaging Experts and Healthcare Services Pty Ltd ABN 18 624 772 756 122 O’Riordan Street, Mascot NSW 2020 Tel: +61 2 9030 0040
==> picture [116 x 30] intentionally omitted <==
About IMEXHS
IMEXHS Limited [ASX: IME] is a leading imaging Software-as-a-Service (SaaS) and ancillary solutions provider with over 120 customers on recurring contracts in over 250 sites, and distributors in 15 countries. Founded in 2012, IMEXHS is known for its innovation in the imaging services market, offering flexible and scalable imaging solutions via its HIRUKO branded suite of solutions for next generation Picture Archiving and Communications System (PACS) and integrated medical imaging systems (including a Radiology Information System (RIS), a Cardiology Information System (CIS) and an Anatomical Pathology Laboratory Information System (APLIS)). The HIRUKO™ system is completely cloud-based, vendor neutral and zero footprint with no need for installed software. The IMEXHS products are designed to increase productivity and save money for end users, with a scalable platform that is configured for the future and enhances patient outcomes. For more information, visit www.imexhs.com
IMEXHS Limited ABN 60 096 687 839
Imaging Experts and Healthcare Services Pty Ltd ABN 18 624 772 756 122 O’Riordan Street, Mascot NSW 2020 Tel: +61 2 9030 0040